Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based ...
Compass Pathways stock rallies as Trump’s new executive order aims at accelerating approval and research of psychedelic ...
CPC review of 5,000 sales finds Compass at 29.7% to 39.5% share in five metros, raising double-ending and private listing ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical ...
The list of products receiving FDA Commissioner priority review vouchers will grow this week to include three psychedelic ...
Colorado home shoppers and sellers are being told to pay closer attention. A new watchdog report warns that one fast-growing ...
Research shows that students with higher EI perform better academically, experience less anxiety, build healthier friendships and are able to handle stress.
Roger Ebert was one of the most respected film critics of all time, and his picks for the 10 best movies ever made include ...
Guardian Pharmacy Services (GRDN) gets a Hold: strong moat and margins offset IRA revenue headwinds, but ~30x NTM P/E limits ...
From Birmingham and Troy to Northville, Rochester, and Novi, these suburban Michigan steakhouses make a strong case for ...
This weekend, President Donald J. Trump signed a groundbreaking Executive Order accelerating research and improving access to psychedelic drugs as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results